White G. Rethinking Your C&GT Value Chain: How to Ensure Readiness for Evolving Specialized Therapy Requirements. April 9, ...

Respective industry and government agendas could significantly reshape the US prescription drug market.

Ensuring that essential treatments reach patients safely and efficiently is an increasing imperative in today's pharma landscape.

“To move at speed, you need to partner with people that are better than you.” This was just one of several memorable quotes ...

A panel discussion breaks down ways for stakeholders to meet temperature-controlled operational demands pertaining to product ...

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at ...

Steffen Lang, president, operations, executive committee member, Novartis, discusses the premise of a keynote session on reimagining operations.

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Chris O’Dell, Turquoise Health’s SVP of market solutions, outlines the key provisions of the recently released ...

New facility is expected to serve as a global hub for accelerating the development of next-generation antibody-drug ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief medical officer, shares his thoughts on the rumors that RFK Jr. could ...

How data-driven insights can help pharma companies balance their revenue management and innovation strategies—including ...

Kevin Hagan, CEO, Pan Foundation, discusses central concerns for patient assistance programs as changes to Medicare and the Inflation Reduction Act take effect.